No Data
No Data
Express News | Tianfeng: Maintains a "buy" rating on jiangsu hengrui pharmaceuticals. Innovation drugs are expected to continue to maintain high-speed growth in the next three years.
tianfeng Securities turnover reached 10 billion yuan
Gelonghui November 1st | A shares tianfeng securities turnover reached 10 billion yuan, now down more than 8%.
Express News | tianfeng: The economic prosperity brought by policies is expected to spread to a wider range of areas.
Express News | 39 stocks had a net inflow of over 0.2 billion yuan of large orders.
"Bull market leaders" collectively celebrate! The performance growth of many companies exceeds 100%, showcasing their strength in self-operated business.
Multiple factors support the sector to improve.
Tianfeng Securities: Tianfeng Securities Co., Ltd. Report for the Third Quarter of 2024
No Data
No Data